Company Profile
Genome Therapeutics Ltd
12392992•Private Limited With Share Capital
Get Full Access
08/01/2020
6 years
6
6
72110
low risk
Company Overview
Registration, classification & business activity
Genome Therapeutics Ltd (12392992) is a private limited with share capital incorporated on 08/01/2020 (6 years old) and registered in london, SE193HF. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Inflex is an innovative drug discovery company at the cutting edge of science who are developing the next generation of cancer therapeutics. we are a growing team of passionate, experienced researchers looking to turn exciting ideas into medicines that make a difference to patients’ lives.
Financial Overview
£642.9K
£278.0K
£364.8K
£362.9K
Key Metrics
6
Employees
6
Directors
24
Shareholders
6
Patents
Board of Directors
Charges
2
Registered
1
Outstanding
0
Part Satisfied
1
Satisfied
Import / Export
Risk Assessment
low risk
International Score
Future Factor
excellent
Performance Rating